Every 10-Q that Albemarle Corporation (ALB) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-Q covers the quarterly report filed between annual reports, so if you follow ALB and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full ALB filings page.
Albemarle Corporation reported net sales of $1.74 billion for the quarter ended June 30, 2026 and net income attributable to the company of $479.9 million, compared with $1.33 billion and $22.9 million a year earlier. Diluted earnings per share attributable to common shareholders were $3.52 versus a loss of $0.16.
For the first half of 2026, net sales were $3.17 billion and net income attributable to the company was $799.1 million, with diluted EPS of $5.87. Operating cash flow rose to $1.06 billion, supporting a reduction of total long‑term debt to $1.88 billion from $3.19 billion at year‑end 2025. The sale of the Refining Solutions business generated $525.2 million of cash and a pre‑tax loss of $95.0 million, while the sale of the 50% Eurecat S.A. stake produced a $42.3 million gain. Energy Storage segment adjusted EBITDA increased to $723.5 million in the quarter, and the Windfield joint venture contributed equity income of $151.6 million in Q2. Albemarle also recorded $33.2 million of restructuring and asset write‑off charges year‑to‑date and expects an additional $70–$90 million of Kemerton Train 1 restructuring costs through 2027. The quarterly common dividend was raised to $0.41 per share beginning with the October 1, 2026 payment.
Albemarle delivered sharply stronger results for the quarter ended March 31, 2026, driven by higher lithium pricing and volumes. Net sales rose 33% to $1.43 billion, while gross margin expanded to 35.1% from 14.5%.
Net income attributable to Albemarle jumped to $319.1 million, and earnings per common share moved from breakeven to $2.35. Adjusted EBITDA more than doubled to $627.5 million, led by the Energy Storage segment.
The company closed the sale of its Refining Solutions business and its 50% Eurecat S.A. stake for about $648 million in cash, recording a $95.0 million loss on the business sale and a $42.3 million gain on Eurecat. Proceeds helped reduce long-term debt from $3.19 billion to $1.88 billion.
Albemarle continued cost actions, including placing Kemerton Train 1 into care and maintenance, which drove $25.9 million of restructuring and asset write-off charges this quarter and is expected to add $80–$100 million of further costs through 2027.
Albemarle Corporation (ALB) reported a narrower quarterly loss as lithium markets remain weak but cash generation improved. For Q3, net sales were $1,307.8 million versus $1,354.7 million a year ago. Operating loss was $216.986 million, including a non-cash $181.1 million goodwill impairment tied to the Refining Solutions reporting unit. Net loss attributable to common shareholders was $202.4 million, or $1.72 per share, compared with a $1.1107 billion loss, or $9.45 per share, last year.
Gross profit improved to $117.6 million from a loss last year as cost actions and lower inventory charges helped. Equity income from unconsolidated investments contributed $60.6 million, led by Windfield. Year to date, operating cash flow rose to $893.8 million, capital expenditures fell to $434.4 million, and cash ended at $1.932 billion. The company recorded $350 million of deferred revenue from a customer for future deliveries of spodumene and lithium salts over five years.
Inventory valuation adjustments declined to $11.1 million as of September 30, 2025. Shares outstanding were 117,697,540 as of October 29, 2025.